Elongation factor 2 — Drug Target

All drugs that target Elongation factor 2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

CD123 Interaction [EPC]

Marketed (1)

• Molecule 129 · Stemline Therapeeutics Inc · CD123 Interaction [EPC] · Oncology
  Tagraxofusp works by binding to CD123 on cancer cells, causing them to die.